Skip to main content
Premium Trial:

Request an Annual Quote

Wyeth and Caprion Expand Protein Biomarker Agreement

NEW YORK, June 28 (GenomeWeb News) - Wyeth has expanded its protein biomarker collaboration with Caprion Pharmaceuticals to identify disease-state biomarkers in the areas of asthma and renal cell carcinoma, Caprion said today.


Under the terms of the agreement, Caprion will conduct proteomic analyses of human blood plasma samples from patients in two separate Phase II clinical trials in asthma and renal cell carcinoma.


Wyeth and Caprion had previously collaborated on preclinical biomarker research in inflammatory disease using Caprion's CellCarta protein expression profiling technology, Caprion said. The companies initiated the collaboration in July 2003.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.